Axsome Therapeutics Watchlist

TOP-5 Price Targets by Analysts on 31.01.25

T. Lämmle
Reading Time: 3 minutes

Carvana [US1468691027]: JPMorgan maintains an Overweight rating and raises the price target from $300 to $350 (41% upside potential) JPMorgan believes that Carvana will experience another year of outperformance in 2025, as the company continues its trend of positive revisions and has potential for further increases in its stock level. Investor focus is expected to shift back to the core areas of the business model that have proven to be differentiated and which have contributed to the recent turnaround in growth and profitability. The online used...

Read this article now with a free account.

Your benefits:

  • Every month, you can read 5 articles from the premium section for free.
  • Monthly 2 trial issues of the Trader newspaper for free.
  • Create a personal watchlist with an overview of news about your stock.
Trader Times
Free account
Here we go!
Image 1Image 2Image 3

Already registered? Log In